Abdominal Imaging / Imagerie abdominaleA Pictorial Review of Hepatobiliary Magnetic Resonance Imaging With Hepatocyte-Specific Contrast Agents: Uses, Findings, and Pitfalls of Gadoxetate Disodium and GADOBENATE DIMEGLUMINE (cas 12700-20-8)
-
Add time:08/25/2019 Source:sciencedirect.com
Magnetic resonance imaging (MRI) has a well-established role as a highly specific and accurate modality for characterizing benign and malignant focal liver lesions. In particular, contrast-enhanced MRI using hepatocyte-specific contrast agents (HSCAs) improves lesion detection and characterization compared to other imaging modalities and MRI techniques. In this pictorial review, the mechanism of action of gadolinium-based MRI contrast agents, with a focus on HSCAs, is described. The clinical indications, protocols, and emerging uses of the 2 commercially available combined contrast agents available in the United States, gadoxetate disodium and gadobenate dimeglumine, are discussed. The MRI features of these agents are compared with examples of focal hepatic masses, many of which have been obtained within the same patient therefore allowing direct lesion comparison. Finally, the pitfalls in the use of combined contrast agents in liver MRI are highlighted.
We also recommend Trading Suppliers and Manufacturers of GADOBENATE DIMEGLUMINE (cas 12700-20-8). Pls Click Website Link as below: cas 12700-20-8 suppliers
Prev:Respiratory-motion artefacts in liver MRI following injection of gadoxetate disodium and GADOBENATE DIMEGLUMINE (cas 12700-20-8): an intra-individual comparative study in cirrhotic patients
Next:Quantitative and qualitative comparison of 0.025 mmol/kg GADOBENATE DIMEGLUMINE (cas 12700-20-8) for abdominal MRI at 1.5 T and 3 T MRI in patients with low estimated glomerular filtration rate) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Contrast-enhanced MRA of the renal and aorto-iliac-femoral arteries: Comparison of GADOBENATE DIMEGLUMINE (cas 12700-20-8) and gadofosveset trisodium08/30/2019
- Non-clinical assessment of safety and gadolinium deposition after cumulative administration of GADOBENATE DIMEGLUMINE (cas 12700-20-8) (MultiHance®) to neonatal and juvenile rats08/29/2019
- Original contributionImproved coronary magnetic resonance angiography using GADOBENATE DIMEGLUMINE (cas 12700-20-8) in pediatric congenital heart disease08/28/2019
- Less is better? Intraindividual and interindividual comparison between 0.075 mmol/kg of GADOBENATE DIMEGLUMINE (cas 12700-20-8) and 0.1 mmol/kg of gadoterate meglumine for cranial MRI08/27/2019
- Quantitative and qualitative comparison of 0.025 mmol/kg GADOBENATE DIMEGLUMINE (cas 12700-20-8) for abdominal MRI at 1.5 T and 3 T MRI in patients with low estimated glomerular filtration rate08/26/2019
- Respiratory-motion artefacts in liver MRI following injection of gadoxetate disodium and GADOBENATE DIMEGLUMINE (cas 12700-20-8): an intra-individual comparative study in cirrhotic patients08/24/2019
- Original articleComparison of gadofosveset (Vasovist®) with GADOBENATE DIMEGLUMINE (cas 12700-20-8) (Multihance®)-enhanced MR angiography for high-grade carotid artery stenosis08/23/2019